Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $94.25, a high estimate of $126.00, and a low estimate of $70.00. This current ...

What Happened? Shares of biotech company BioMarin Pharmaceutical (NASDAQ:BMRN) jumped 9.6% in the pre-market session after ...

BioMarin exceeded Q4 earnings expectations, raised 2025 guidance, and projected strong Voxzogo growth. Analysts increased price targets following the results.

Scott Whitaker sent a letter to HHS calling for staff cuts at the FDA to be reversed, arguing patient care and U.S.

When Cathy Tie started Locke Bio, a Culver City-based digital health startup, she had spent years as a venture capitalist seeing a trend in the digital ...

Mr. Iwicki stated, “I am proud of the work we have done at KALA utilizing our MSC-S platform, and I am very excited about the potential of our lead product candidate, KPI-012 for the treatment of PCED ...

As an organization founded with an SBIR NIH/NCI grant to develop a patient-centric, AI-driven Deep Learning Clinical Trial ...

The Chief Operating Offi­cer and Co-Founder of Syn­dicate Bio, Estelle Dogbo, has stated that the history of the company, Syndicate bio was founded in 2023 out of the realisation that glob­al research ...

In this article, we are going to take a look at where BridgeBio Pharma Inc. (NASDAQ:BBIO) stands against the other stocks. Ten companies kicked off this week’s trading with significant losses ...

Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a regulatory affairs, quality, compliance, project management and technology transfer support consulting firm that provides ...